Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01469481 · ClinicalTrials.gov registry record · Phase 1
Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01469481 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 6 participants.
The verdict
NCT01469481, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the excretion balance, metabolic profile and the routes of excretion of \[14C\]PF-04991532 in healthy adult male subjects.
Interventions
- DRUG PF-04991532
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-11 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01469481
The ClinicalTrials.gov registry entry for NCT01469481 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-04991532 is the first listed.
NCT01469481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01469481 about?
NCT01469481 is a clinical study titled "Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532". The purpose of this study is to evaluate the excretion balance, metabolic profile and the routes of excretion of \[14C\]PF-04991532 in healthy adult male subjects.
What is the current status of trial NCT01469481?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2011-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01469481?
The interventions under investigation include: PF-04991532 (DRUG).
Who is sponsoring clinical trial NCT01469481?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.